Paul Workman

47.6k citations
606 papers · 40.3k · 9 hit papers · h-index 100

Impact in

Papers in

    • Bioactive Compounds and Antitumor Agents 78
    • Heat shock proteins research 113
    • PI3K/AKT/mTOR signaling in cancer 56
    • Cancer therapeutics and mechanisms 48

Paul Workman

602 papers receiving 38.5k citations

Paul Workman's Hit Papers

Challenges to curing primary brain tumours 2019 · 736 citations
7360+12+25Years since publication5001k1.5k

Peers

Paul Workman
Comparison fields: 5 of 170
  • Toxicology 2k
  • Cancer Research 3.8k
  • Molecular Biology 17.1k
  • Oncology 4.5k
  • Genetics 1.7k
Replace Yves G. Pommier with:
Yves G. Pommier United States
Edward A. Sausville United States
Kurt W. Kohn United States
Ting‐Chao Chou United States
Daniel D. Von Hoff United States
Paul Gerard Guy Richardson United States
Kenneth Carl Anderson United States
Godefridus J. Peters Netherlands
Garth Powis United States
William Douglas Figg United States
Paul Workman relative to Yves G. Pommier United States Yves G. Pommier's profile →
Citations per field
00.5×1.5×2.2×
Yves G. Pommier · 1×
Citations per year

Countries citing papers authored by Paul Workman

Since Specialization
Citations

This map shows the geographic impact of Paul Workman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Workman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Workman more than expected).

Fields of papers citing papers by Paul Workman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Workman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Workman. The network helps show where Paul Workman may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Workman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Workman Line = papers co-authored together Paul Workman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 606 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Hit paper breakdown →
20181618
2
Guidelines for the welfare and use of animals in cancer research
Hit paper breakdown →
20101215
3
Imaging biomarker roadmap for cancer studies
Hit paper breakdown →
2016881
4
Combinatorial drug therapy for cancer in the post-genomic era
Hit paper breakdown →
2012874
5
Challenges to curing primary brain tumours
Hit paper breakdown →
2019736
6
The Identification of 2-(1 H -Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d ]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer
Hit paper breakdown →
2008683
7
The promise and peril of chemical probes
Hit paper breakdown →
2015673
8
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
Hit paper breakdown →
2012483
9 2002475
10 2008475
11 2007466
12 2002445
13 2005435
14 2005420
15 2008415
16 2007394
17 2008378
18 2017316
19 2006314
20 2007312

About Paul Workman

Paul Workman is a scholar working on Toxicology, Molecular Biology, Pharmacology, Cancer Research and Computational Theory and Mathematics, having authored 606 papers that have together received 40.3k indexed citations. Recurring topics across this work include Heat shock proteins research (113 papers), Bioactive Compounds and Antitumor Agents (78 papers), Pharmacogenetics and Drug Metabolism (71 papers), PI3K/AKT/mTOR signaling in cancer (56 papers), Computational Drug Discovery Methods (52 papers), Cancer therapeutics and mechanisms (48 papers), Cancer, Hypoxia, and Metabolism (43 papers) and Radiation Therapy and Dosimetry (34 papers). The work is most often cited by research in Toxicology (2k citations), Cancer Research (3.8k citations), Molecular Biology (17.1k citations), Oncology (4.5k citations) and Genetics (1.7k citations). Paul Workman has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paul Andrew Clarke, Bissan Al‐Lazikani, Udai Banerji, Marissa V. Powers, Florence I. Raynaud, Swee Y. Sharp, Michael I. Walton, Ian F. Collins, Alison Maloney and Michelle Dawn Garrett. Their work appears in journals such as British Journal of Cancer, Biochemical Pharmacology, Cancer Research, Molecular Cancer Therapeutics and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact